TETANUS of the newborn, formerly nearly always fatal, has been more amenable to therapy in recent years; antiserum, sedation, and penicillin have improved the prognosis.* The nutrition of these patients has continued to present a problem to pediatricians; at the meeting of the American Pediatric Society in 1954 the problem was referred to as very difficult.8 It is therefore the purpose of the present report to point out the advantages of the percutaneous intravenous drip when combined with the "room within a room" protective effect of an incubator. Most of the baby's needs may be satisfied without repeated pain, handling, noise, flashing lights, or other undesirable stimuli. A decrease in number and intensity of such stimuli is followed by a decreased incidence of those events which are most likely to end the case fatally: tetanic convulsive or laryngospastic episodes. It also follows that the amount of sedation may be
LAWLER HJ. TREATMENT OF TETANUS OF THE NEWBORN. AMA Am J Dis Child. 1955;90(6):701–702. doi:10.1001/archpedi.1955.04030010703008
Monkeypox Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.